Microscopic bioelectronic devices, known as "circulatronics," have the potential to travel through the body's circulatory system and autonomously self-implant in targeted regions of the brain. These implants are wirelessly powered and can deliver focused electrical stimulation, offering a new approach to treating diseases such as Alzheimer’s, multiple sclerosis, and cancer.
Imagine clinicians placing tiny electronic chips in the brain via a simple arm injection. This method could replace traditional surgery, reducing risks and costs associated with invasive procedures.
Researchers at MIT have developed microscopic, wireless bioelectronic implants that can locate and implant themselves in specific brain areas. Their study on mice demonstrated that after injection, these devices could autonomously find a precise brain region without human intervention.
"These minuscule implants can identify and travel to a specific brain region without the need for human guidance."
Images related to this research are available on the MIT News office website under a Creative Commons Attribution Non-Commercial No Derivatives license. Altering images is limited to cropping, and proper credit must be given, or attributed to "MIT" if no credit is specified.
"What if clinicians could place tiny electronic chips in the brain that electrically stimulate a precise target, through a simple injection in the arm?"
The development of these bioelectronic devices marks a significant advance toward safer, more efficient brain disease treatments.
Author's summary: Tiny wireless brain implants that self-navigate to target regions through the bloodstream could revolutionize treatment by avoiding surgery and focusing electrical stimulation precisely.